Log in to save to my catalogue

New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by...

New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_384af2c64a0143f7b07d35ffbf8a2408

New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

EPNs comprise a heterogeneous group of neuroepithelial tumors, accounting for about 10% of all intracranial tumors in children and up to 30% of brain tumors in those younger than 3 years. Actually, the pattern therapy for low-grade EPNs includes complete surgical resection followed by radiation therapy. Total surgical excision is often not possible...

Alternative Titles

Full title

New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_384af2c64a0143f7b07d35ffbf8a2408

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_384af2c64a0143f7b07d35ffbf8a2408

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-019-45799-4

How to access this item